Latest Headlines

Latest Headlines

Q3 biotech venture investing makes a boisterous leap

The life sciences industry gained a blast of good news on the venture front today. The National Venture Capital Association and PricewaterhouseCoopers outlined a buoyant set of numbers for the...

Third Rock bankrolls a new biotech to tackle genetic heart disease

Third Rock Ventures has dipped back into its second fund for a $38 million A round to launch a new drug developer which plans to get into the genetic nitty-gritty of heart disease.